Latest ALS (Lou Gehrig's Disease) news
In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in Second Review
posted September 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Panel Skeptical of Controversial ALS Drug Ahead of Vote
posted September 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
New ALS Drug Approved in Canada While Still Under FDA Review
posted June 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Advisory Panel Narrowly Votes Against New ALS Drug
posted March 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Hospital-Treated Infections Earlier in Life Tied to Alzheimer, Parkinson Disease Risk 
FDA Reviewers Give Thumbs Down to New ALS Drug Monthly Specialist Briefings
Stay Connected
